elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34858284-2009409F-B953-4CB1-A6AC-2F3679AAEB5D
Q34858284-2009409F-B953-4CB1-A6AC-2F3679AAEB5D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34858284-2009409F-B953-4CB1-A6AC-2F3679AAEB5D
Adjuvant chemotherapy in older women with early-stage breast cancer.
P2860
Q34858284-2009409F-B953-4CB1-A6AC-2F3679AAEB5D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34858284-2009409F-B953-4CB1-A6AC-2F3679AAEB5D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2e2136cf8725e1541788a6aa56b1b11afbc74662
P2860
Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial.